UK Nod For Pfizer’s COVID-19 Oral Treatment

Pfizer Aims For Early 2022 To Deliver First Treatment Courses To Great Britain

 
• By Vibha Sharma

Pfizer’s Paxlovid is the second take-at-home COVID-19 treatment approved for use in the UK.

Pfizer Covid-19 Paxlovid treatment box isolated on a white background
Paxlovid is a novel coronavirus-specific protease inhibitor • Source: Alamy

More from Approvals

More from Product Reviews